IDEAS home Printed from https://ideas.repec.org/a/ssi/jouesi/v8y2020i2p1245-1266.html
   My bibliography  Save this article

Comparative analysis of social and economic efficiency in managing product innovations in the pharmaceutic industry

Author

Listed:
  • Zhibek Omarkhanova

    (S. Seifullin Kazakh Agro Technical University, Kazakhstan)

  • Danagul Tleuzhanova

    (S. Seifullin Kazakh Agro Technical University, Kazakhstan)

  • Aigul Zholmukhanova

    (S. Seifullin Kazakh Agro Technical University, Kazakhstan)

  • Zamira Mukhambetova

    (S. Seifullin Kazakh Agro Technical University, Kazakhstan)

  • Sholpan Alpeissova

    (S. Seifullin Kazakh Agro Technical University, Kazakhstan)

Abstract

Despite the variety of studies of modern innovative projects within the global pharmaceutical industry, the study of the management system for innovative projects in the pharmaceutical industry is relevant. The pharmaceutical business has a high social role in the country's economy, meeting the needs of the population in providing the necessary products. This is what determines the significant influence of the state on this sphere of economic activity, which is expressed in the mandatory fulfillment of a number of rigidly and clearly established requirements, due to which the observance of the rights of citizens in the possibility of obtaining high-quality pharmaceutical products will be ensured.The aim of the study is to consider the socio-economic characteristics of managing product innovations in pharmaceuticals (leading pharmaceutical markets) based on assessing the level of innovative activity of pharmaceutical companies, which addresses the problems of managing their role and importance in the healthcare system of Kazakhstan.

Suggested Citation

  • Zhibek Omarkhanova & Danagul Tleuzhanova & Aigul Zholmukhanova & Zamira Mukhambetova & Sholpan Alpeissova, 2020. "Comparative analysis of social and economic efficiency in managing product innovations in the pharmaceutic industry," Entrepreneurship and Sustainability Issues, VsI Entrepreneurship and Sustainability Center, vol. 8(2), pages 1245-1266, December.
    • Handle: RePEc:ssi:jouesi:v:8:y:2020:i:2:p:1245-1266
    DOI: 10.9770/jesi.2020.8.2(74)
    as

    Download full text from publisher

    File URL: https://jssidoi.org/jesi/uploads/articles/30/Omarkhanova_Comparative_analysis_of_social_and_economic_efficiency_in_managing_product_innovations_in_the_pharmaceutic_industry.pdf
    Download Restriction: no
    File URL: https://jssidoi.org/jesi/article/756
    Download Restriction: no
    File URL: https://libkey.io/10.9770/jesi.2020.8.2(74)?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Leonid Kogan & Dimitris Papanikolaou & Amit Seru & Noah Stoffman, 2017. "Technological Innovation, Resource Allocation, and Growth," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 132(2), pages 665-712.
    2. Gamba, Simona, 2017. "The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector," World Development, Elsevier, vol. 99(C), pages 15-27.
    3. Hu, Jia & Mossialos, Elias, 2016. "Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts," Health Policy, Elsevier, vol. 120(5), pages 519-534.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wang, Quan-Jing & Feng, Gen-Fu & Chen, Yin E. & Wen, Jun & Chang, Chun-Ping, 2019. "The impacts of government ideology on innovation: What are the main implications?," Research Policy, Elsevier, vol. 48(5), pages 1232-1247.
    2. Hickfang, Michael & Holder, Ulrike, 2018. "The impact of stock options on risk-taking: Founder-CEOs and innovation," Discussion Papers of the Institute for Organisational Economics 12/2018, University of Münster, Institute for Organisational Economics.
    3. Hasan, Tahseen & John, Kose & Teng, Haimeng & Wu, Qiang, 2024. "Creative corporate culture and corporate tax avoidance," The British Accounting Review, Elsevier, vol. 56(3).
    4. Ilona Babenko & Benjamin Bennett & John M Bizjak & Jeffrey L Coles & Jason J Sandvik, 2023. "Clawback Provisions and Firm Risk," The Review of Corporate Finance Studies, Society for Financial Studies, vol. 12(2), pages 191-239.
    5. Hyoseok (David) Hwang, 2023. "The real effects of local mutual funds: Evidence from corporate innovation," International Review of Finance, International Review of Finance Ltd., vol. 23(2), pages 272-300, June.
    6. Zhao, Jun & Shahbaz, Muhammad & Dong, Kangyin, 2022. "How does energy poverty eradication promote green growth in China? The role of technological innovation," Technological Forecasting and Social Change, Elsevier, vol. 175(C).
    7. Kimura, Yosuke, 2024. "Market-based patent value of green transformation technologies," Finance Research Letters, Elsevier, vol. 68(C).
    8. Pauly, Stefan & Stipanicic, Fernando, 2021. "The creation and diffusion of knowledge: Evidence from the Jet Age," CEPREMAP Working Papers (Docweb) 2112, CEPREMAP.
    9. Bostan, Ibrahim & Mian, G. Mujtaba, 2023. "Do insiders trade on innovation?," Journal of Contemporary Accounting and Economics, Elsevier, vol. 19(1).
    10. Max Nathan & Anna Rosso, 2017. "Innovative events," Development Working Papers 429, Centro Studi Luca d'Agliano, University of Milano, revised 08 Apr 2019.
    11. Simon Kinyua Njeru & Dr. Robert Mang’ana & Dr. Enos Anene, 2025. "Strategy Implementation and Performance of Manufacturing Pharmaceutical Companies in Kenya," Journal of Business and Strategic Management, CARI Journals Limited, vol. 10(5), pages 36-62.
    12. Morana, Claudio, 2014. "Insights on the global macro-finance interface: Structural sources of risk factor fluctuations and the cross-section of expected stock returns," Journal of Empirical Finance, Elsevier, vol. 29(C), pages 64-79.
    13. Stephen G. Dimmock & Jiekun Huang & Scott J. Weisbenner, 2022. "Give Me Your Tired, Your Poor, Your High-Skilled Labor: H-1B Lottery Outcomes and Entrepreneurial Success," Management Science, INFORMS, vol. 68(9), pages 6950-6970, September.
    14. Alex Bell & Raj Chetty & Xavier Jaravel & Neviana Petkova & John Van Reenen, 2019. "Who Becomes an Inventor in America? The Importance of Exposure to Innovation," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 134(2), pages 647-713.
    15. Zhou, Xiaoxiao & Jia, Mengyu & Li, Wenqing & Zhao, Xin & Gatto, Andrea & Ma, Xiaowei, 2024. "Higher education or scientific research: Which one contributes more to China's green innovation?," Socio-Economic Planning Sciences, Elsevier, vol. 94(C).
    16. Jiang, Mengting & Gong, Pu & Kong, Dongmin, 2024. "Market access and firm productivity: Evidence from a natural experiment," Finance Research Letters, Elsevier, vol. 70(C).
    17. Hong Zhang & Chudi Yang & Weiguo Zhong, 2024. "Do political ties facilitate or inhibit firm innovation in China? An examination of the institutional structure," Asia Pacific Journal of Management, Springer, vol. 41(4), pages 2059-2089, December.
    18. Cameron D. Miller & Puay Khoon Toh, 2022. "Complementary components and returns from coordination within ecosystems via standard setting," Strategic Management Journal, Wiley Blackwell, vol. 43(3), pages 627-662, March.
    19. Tubiana, Matteo & Miguelez, Ernest & Moreno, Rosina, 2022. "In knowledge we trust: Learning-by-interacting and the productivity of inventors," Research Policy, Elsevier, vol. 51(1).
    20. Raffaele Morandi Stagni & Andrea Fosfuri & Juan Santaló, 2021. "A bird in the hand is worth two in the bush: Technology search strategies and competition due to import penetration," Strategic Management Journal, Wiley Blackwell, vol. 42(8), pages 1516-1544, August.

    More about this item

    Keywords

    pharmaceutical industry; product innovation; innovative development; innovation activity; management; development strategy;
    All these keywords.

    JEL classification:

    • M21 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Business Economics - - - Business Economics
    • O11 - Economic Development, Innovation, Technological Change, and Growth - - Economic Development - - - Macroeconomic Analyses of Economic Development

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ssi:jouesi:v:8:y:2020:i:2:p:1245-1266. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Manuela Tvaronaviciene (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.